Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 457 clinical trials
Cardiac Arrest Incidence and Outcome Among Patients With COVID-19 in French ICUs

The incidence of unexpected in-ICU cardiac arrest (ICUCA) due to COVID-19 is still unknown. Additionally, outcome of COVID-19 patients admitted in ICU for an out-of-hospital cardiac arrest (OHCA) is also undescribed.

resuscitation
coronavirus infection
covid-19
SARS
acute respiratory syndrome (sars)
  • 0 views
  • 19 Feb, 2024
  • 41 locations
PHenotyping patiENts Admitted to Hospital With cOvid-19 Infection and idenTifYing Prognostic markErs

PHENOTYPE is an investigator-led, observational cohort study which aims to explore the long-term outcomes of patients with COVID-19 infection and to identify potential risk factors and biomarkers that can prognosticate disease severity and trajectory.

covid-19
  • 0 views
  • 19 Feb, 2024
  • 1 location
Acute Kidney Injury and Renal Outcomes for COVID-19 Patients in Intensive Care Units

The aims of this study are: To describe incidence, severity and mortality associated with AKI during covid-19 infection in ICU To identify specific risk factors for AKI To explore pathophysiologic mechanism of AKI during COVID-19 infection

  • 0 views
  • 19 Feb, 2024
  • 1 location
Clinical Scores for Outcome Prediction in Patients With Severe COVID-19 Pneumonia Requiring ECMO

The prognosis of patients with severe COVID-19 disease, whose lungs are so severely diseased that they need to be supported by veno-venous ECMO (extracorporeal membrane oxygenation), is difficult to assess so far.

covid-19
SARS
pneumonia
extracorporeal membrane oxygenation
acute respiratory syndrome (sars)
  • 0 views
  • 19 Feb, 2024
  • 1 location
Th1/Th2/Th17/TREG and TLRs Activation/KIR for COVID 19 Prediction of Outcome

To ascertain globally the changes in the cytokines involved and TLRs/KIR activation in patients admitted to the hospital with a COVID-19 diagnosis, and the changes after initiation of the different therapies

cytokines
covid-19
  • 0 views
  • 19 Feb, 2024
  • 1 location
Risk Prediction and Therapy Monitoring in Patients With SARS-Cov-2 Infection / COVID 19

Approximately 15% of patients with SARS-CoV-2 infection / COVID-19 develop a severe clinical course. This leads to hospitalization and potentially life threatening complications such as pneumonia and respiratory failure.

respiratory failure
covid-19
early diagnosis
SARS
pneumonia
  • 0 views
  • 19 Feb, 2024
  • 1 location
Microvascular Flow and Reactivity in Patients Presenting in the Acute Phase of COVID-19.

Considering that the intensity of systemic microvascular changes in patients in the acute phase of COVID-19 could be related to disease progression and prognosis, the present cross-sectional and observational study aims to investigate the presence of endothelial dysfunction in these patients, also looking for to evaluate associations between the presence …

covid-19
SARS
endothelial dysfunction
acute respiratory syndrome (sars)
  • 0 views
  • 19 Feb, 2024
  • 1 location
Lung Function Exercise Capacity and Health-Related Quality of Life After Severe COVID-19

The medium and long-term impact in survivors of severe COVID-19 on lung function, exercise capacity and health-related quality of life remains to be determined.

fever
covid-19
respiratory tract infection
chest imaging
acute respiratory distress
  • 0 views
  • 19 Feb, 2024
  • 5 locations
A Cross-sectional and Cohort Study of COVID-19 Patients With Post - Discharge Dysfunction

Post-discharge rehabilitation regimens for covid-19 patients have not been supported by high-quality evidence-based medical evidence.The first part of this study is a cross-sectional study.The contents of the study were the factors related to the dysfunction of COVID - 19 patients after discharge from the hospital in Wuhan.The second part of …

rehabilitation care
  • 0 views
  • 19 Feb, 2024
  • 1 location
COVID - AirPollution

Epidemiological data have related particulate matter (PM), nitrogen dioxide (NO2) and ozone (O3) to COVID-19 morbidity and mortality at the population level. Air pollution may be related to an increase in the COVID-19 severity and lethality through its impact on chronic diseases such as cardiovascular and respiratory diseases and diabetes …

  • 0 views
  • 19 Feb, 2024
  • 11 locations